These data clearly show that the injection of OT1 T-cell biomaterial brought a major change of the tumor immune environment, with contrasting effects on the proportions of CD8+ T-cells and neutrophils, and exhibiting a high infiltration of the injected OT1 T-cells. The gene discussed is CD8A; the disease is neoplasm.